KyungMann Kim
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Biostatistics BiologyGoogle:
"KyungMann Kim"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| D'Angelo CR, Hall A, Woo KM, et al. (2020) Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications. Leukemia Research. 96: 106419 |
| Kates AE, Gaulke I, De Wolfe T, et al. (2020) Fecal microbiota transplantation for patients on antibiotic treatment with infection history (GRAFT): Study protocol for a phase II, randomized, double-blind, placebo-controlled trial to prevent recurrent infections. Contemporary Clinical Trials Communications. 18: 100576 |
| Albertini MR, Yang RK, Ranheim EA, et al. (2018) Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunology, Immunotherapy : Cii |
| Chang JE, Carmichael LL, Kim K, et al. (2017) VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study. Clinical Lymphoma, Myeloma & Leukemia |
| Erbe AK, Wang W, Carmichael L, et al. (2017) Neuroblastoma Patients' KIR and KIR-ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Gee JR, Saltzstein DR, Kim K, et al. (2017) A phase II randomized, double-blind, presurgical trial of Polyphenon E in bladder cancer patients to evaluate pharmacodynamics and bladder tissue biomarkers. Cancer Prevention Research (Philadelphia, Pa.) |
| Erbe AK, Wang W, Carmichael L, et al. (2017) Abstract LB-048: Impact of KIR/KIR ligand genotype for neuroblastoma patients in a Phase 3 COG immunotherapy trial Cancer Research. 77 |
| Rampurwala M, Wisinski KB, Burkard ME, et al. (2016) Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer. Investigational New Drugs |
| Chang JE, Havighurst T, Kim K, et al. (2016) Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study. British Journal of Haematology |
| Erbe AK, Wang W, Carmichael L, et al. (2016) Impact of KIR/KIR ligand genotype for neuroblastoma patients in a phase III COG immunotherapy trial. Journal of Clinical Oncology. 34: e14014-e14014 |